Author Details

Остроумова, Ольга Дмитриевна

Issue Section Title File
Vol 9, No 4 (2012) Articles Diurnal blood pressure variability as a risk factor for complications of arterial hypertension
Vol 10, No 1 (2013) Articles Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension
Vol 10, No 2 (2013) Articles Efficacy of irbesartan in arterial hypertension and metabolic syndrome
Vol 10, No 3 (2013) Articles Covremennye predstavleniya ob ideal'noy kombinatsii antigipertenzivnykh preparatov dlya profilaktiki insul'ta
Vol 11, No 1 (2014) Articles The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS») PDF
(Rus)
Vol 11, No 1 (2014) Articles New trends in the treatment of hypertension in 2013: the renaissance of pulse pressure PDF
(Rus)
Vol 11, No 2 (2014) Articles The benefits of candesartan usage in the treatment of arterial hypertension PDF
(Rus)
Vol 11, No 4 (2014) Articles First results of the Russian database of international prospective observational registry variability of blood pressure in patients with hypertension PDF
(Rus)
Vol 11, No 3 (2014) Articles The combination therapy in arterial hypertension: opportunities of the fixed combination of irbesartan andhydrochlorothiazide(Koaprovel’) PDF
(Rus)
Vol 12, No 2 (2015) Articles The hardness of the vessel wall in patients with arterial hypertension PDF
(Rus)
Vol 12, No 1 (2015) Articles The association of arterial hypertension and ischemic heart disease is the main problem in modern cardiology practice PDF
(Rus)
Vol 12, No 4 (2015) Articles From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift PDF
(Rus)
Vol 13, No 1 (2016) Articles The role of b-blockers in treatment of hypertension, according to Russian and European experts PDF
(Rus)
Vol 12, No 4 (2015) Articles A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial PDF
(Rus)
Vol 14, No 4 (2017) Articles Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging PDF
(Rus)
Vol 14, No 3 (2017) Articles The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations PDF
(Rus)
Vol 15, No 1 (2018) Articles Fixed combination of amlodipine and lisinopril effectiveness in hypertensive smokers PDF
(Rus)
Vol 15, No 2 (2018) Articles The influence of antyhypertensive therapy of valsartan and fixed combination with hydrochlorothiazide use on pulse-wave velocity and central arterial pressure in patients with arterial hypertension of 1-2 grades in international VICTORY clinical trial PDF
(Rus)
Vol 15, No 2 (2018) Articles Stroke prevention in patients with atrial fibrillation and comorbidities PDF
(Rus)
Vol 15, No 4 (2018) Articles The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities PDF
(Rus)
Vol 6, No 4 (2009) Articles Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)
Vol 6, No 4 (2009) Articles Arterial hypertension in the elderly and higher mental functions. Possibilities of an-tihypertensive therapy withArifon retard in the prevention of dementia.
Vol 16, No 3 (2019) Articles Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty PDF
(Rus)
Vol 16, No 2 (2019) Articles Drug-induced arterial hypertension PDF
(Rus)
Vol 16, No 4 (2019) Articles Target blood pressure levels in patients with arterial hypertension and frailty PDF
(Rus)
Vol 17, No 1 (2020) Review Evidence base regarding target levels of arterial pressure in patients after a stroke: focus on a geriatric population PDF
(Rus)
Vol 17, No 2 (2020) Original Article First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension PDF
(Rus)
Vol 17, No 2 (2020) Review COVID-19: a patient with cardiovascular disease at high risk PDF
(Rus)
Vol 17, No 3 (2020) Articles Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II PDF
(Rus)
Vol 17, No 3 (2020) Expert opinion Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19 PDF
(Rus)
Vol 18, No 1 (2021) Expert opinion Expert consensus. Effect of antihypertensive therapy on cognitive functions PDF
(Rus)
Vol 18, No 1 (2021) Original Article Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies